10982-1-AP

antibody from Proteintech Group

Targeting: OSMR OSMRB, OSMRbeta

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

10982-1-AP

Provider

Proteintech Group

Proper citation

Proteintech Cat#10982-1-AP, RRID:AB_2156583

Product name

OSMR antibody

Antibody type

Polyclonal

Description

KD/KO validated OSMR antibody (Cat. #10982-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, monkey and has been validated for the following applications: WB, ELISA.

Reactivity

Human, Simian

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Repression of Osmr and Fgfr1 by miR-1/133a prevents cardiomyocyte dedifferentiation and cell cycle entry in the adult heart.

Valussi M, Besser J, Wystub-Lis K, Zukunft S, Richter M, Kubin T, Boettger T, Braun T
Science advances 2021 Oct 15;7(42):eabi6648

---

Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.

Cao JY, Guo Q, Guan GF, Zhu C, Zou CY, Zhang LY, Cheng W, Wang GL, Cheng P, Wu AH, Li GY
Aging 2020 Jan 29;12(2):1656-1684

---

CD11b⁺ cells markedly express the itch cytokine interleukin-31 in polymorphic light eruption.

Patra V, Strobl J, Gruber-Wackernagel A, Vieyra-Garcia P, Stary G, Wolf P
The British journal of dermatology 2019 Nov;181(5):1079-1081

---

Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.

Guo Q, Guan GF, Cao JY, Zou CY, Zhu C, Cheng W, Xu XY, Lin ZG, Cheng P, Wu AH
Journal of cellular physiology 2019 Jan 28;

---

IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis.

Nobbe S, Dziunycz P, Mühleisen B, Bilsborough J, Dillon SR, French LE, Hofbauer GF
Acta dermato-venereologica 2012 Jan;92(1):24-8

---

Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling.

Kubin T, Pöling J, Kostin S, Gajawada P, Hein S, Rees W, Wietelmann A, Tanaka M, Lörchner H, Schimanski S, Szibor M, Warnecke H, Braun T
Cell stem cell 2011 Nov 4;9(5):420-32